NEW BRUNSWICK, NJ, February 17, 2006 -- Johnson & Johnson (NYSE: JNJ) today announced the completion of its previously announced acquisition of Animas Corporation, an insulin delivery company.

Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 115,600 men and women in 57 countries and sell products throughout the world.

Press Release Index

Home | Company | Products | Diabetes Care | OneTouch Gold | Professionals | Feedback | Around the World

The health information on this Web site is for general background purposes and is not a substitute for medical advice or treatment for specific conditions. Seek prompt medical attention for health care questions you have. Consult your physician before making changes to your medication, diet, fitness program, or blood glucose testing schedules.

This site is intended for visitors from the United States and published by LifeScan, Inc., which is solely responsible for its contents.
By using this site, you agree to our Legal Notice and Privacy Policy.
AdvaMed Guidelines.
© LifeScan, Inc. 1996-. All trademarks are the property of their respective owners.